In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Some of Florida’s opossums may soon start dying for a noble cause. A few select marsupials fitted with tracking collars may ...
Google may expand its unsupported robots.txt rules list using HTTP Archive data and could broaden how it handles common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results